GL1X · GenesisL1 explorer

Research workbench

Solution structure of the VAV1 SH2 domain complexed with a tyrosine- phosphorylated peptide from SLP76

Analyse Solution structure of the VAV1 SH2 domain complexed with a tyrosine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ROR
Type
protein
Length
153 residues
Chains
2
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene vav; 15-meric peptide from lymphocyte cytosolic protein 2
UniProt
P15498, Q13094
Pockets
2 · best druggability 0.41

Structure

solution nmr · 2 distinct chains · 16% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene vavprotein13817% helix, 17% strandP15498
B15-meric peptide from lymphocyte cytosolic protein 2protein150% helix, 0% strandQ13094

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11190.410.7623empty
2630.340.7717empty

Interfaces

1 interface between chains.

  • A–B · 592 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 2ROR · Solution structure of the VAV1 SH2 domain complexed with a tyrosine-phosphorylated… · the same entry in another collection · chain A against A, TM-score 1.00
  • P15498 · AlphaFold monomer V2.0 prediction for proto-oncogene vav (P15498) · a predicted model of the same protein · chain A against A, TM-score 0.70
  • Q13094 · AlphaFold monomer V2.0 prediction for lymphocyte cytosolic protein 2 (Q13094) · a predicted model of the same protein · chain B against A, TM-score 0.18

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.